Natco settles patent dispute with Onyx Therapeutics for blood cancer drug Carfilzomib

The settlement allows Natco and its partner Breckenridge to launch the generic version of Kyprolos in 2027 or sooner depending on certain occurrences.

from Moneycontrol Business News http://bit.ly/30TCpWv